Over the past couple of weeks, we have been sharing a slide series on the use of CGM and the value for our patients. This has been one of our most viewed slide series and indicates to us that you want to offer your patients the best technology for managing …

A 60-year-old woman with type 2 diabetes and no serious health complications began an exercise program as part of a research study. It involved doing an hour of moderate aerobic exercise three days per week in a supervised setting (at a local Y). She showed up to all the training sessions, stating about a month into the 12-week training program that she was so happy to be active again, that she felt so much better physically and mentally and felt like she had “found herself” again.

Javed Butler, MD, MPH, MBA, is the Patrick A. Lehan Professor and Chairman of the Department of Medicine Department at University of Mississippi. He is also Professor of Physiology and Biophysics. Prior to joining the University of Mississippi, he was Charles A. Gargano Professor and Director of the Division of Cardiovascular Medicine and Co-Director of the Heart Institute at Stony Brook University, New York. He had served as the Director for heart failure research at Emory University and Director of the heart and heart-lung transplant programs at Vanderbilt University prior to that.

In this week's Homerun Slides, looking at multiple daily injections while using CGM.

This chapter will concentrate on the monogenic disorders of the beta cell that account for 1–2% of diabetes. They are discrete disorders, which are a significant cause of diabetes in their own right. Correct molecular diagnosis is important to predict clinical course, explain other associated clinical features, enable genetic counseling, diagnose family members, and most importantly guide appropriate treatment. In addition to this clinical importance, the discovery and study of monogenic disorders has given further insight into the physiology and pathophysiology of the beta cell.

In this Exclusive Interview transcript, Javed Butler talks with Diabetes in Control publisher Steve Freed during the ADA 2018 convention in Orlando about the relationship between diabetes and heart failure, the importance of managing patients' cardio risks as well as A1C, and increasing attention to heart failure outcomes.

In this Exclusive Interview, Javed Butler talks with Diabetes in Control publisher Steve Freed during the ADA 2018 convention in Orlando about the importance of managing patients' cardio risks as well as A1C, and increasing attention to heart failure outcomes.

In part 1 of this Exclusive Interview, Javed Butler talks with Diabetes in Control Publisher Steve Freed about the use of SGLT to lower risk of heart disease.

In part 2 of this Exclusive Interview, Javed Butler talks with Diabetes in Control Publisher Steve Freed about the four most important treatment goals when helping a patient who has diabetes.

In part 3 of this Exclusive Interview, Javed Butler explains the focus on heart disease versus diabetes as a major cause of mortality in a conversation with Diabetes in Control Publisher Steve Freed.